IRLAB Therapeutics AB (publ) (STO:IRLAB.A)
Sweden · Delayed Price · Currency is SEK 1.268
+0.030 (2.42%)
At close: Jun 11, 2026
IRLAB Therapeutics AB Market Cap
IRLAB Therapeutics AB has a market cap or net worth of 107.7 million as of June 11, 2026. Its market cap has decreased by -70.38% in one year.
Market Cap
107.70M
Enterprise Value
84.00M
Revenue
92.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.27
Market Cap Chart
Since February 28, 2017, IRLAB Therapeutics AB's market cap has decreased from 413.00M to 107.70M, a decrease of -73.92%. That is a compound annual growth rate of -13.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 105.15M | -37.16% |
| Dec 30, 2025 | 167.33M | -69.99% |
| Dec 30, 2024 | 557.59M | 43.33% |
| Dec 29, 2023 | 389.01M | -80.42% |
| Dec 30, 2022 | 1.99B | -12.75% |
| Dec 30, 2021 | 2.28B | 4.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alligator Bioscience AB | 126.88M |
| NextCell Pharma AB | 120.08M |
| Simris Group AB (PUBL) | 116.62M |
| Biovica International AB | 105.67M |
| OncoZenge AB | 96.65M |
| AcouSort AB | 92.91M |
| Scandinavian ChemoTech AB | 92.14M |
| Annexin Pharmaceuticals AB | 91.77M |